ArticleOncoimmunology
Zoledronic acid inhibits NFAT and IL-2 signaling pathways in regulatory T cells and diminishes their suppressive function in patients with metastatic cancer.
Dhifaf Sarhan et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
17 papers cite it
cites it